Community Answer

Answered by Dr. Emily Carter, MD

Mounjaro (tirzepatide) is primarily approved for the treatment of type 2 diabetes, not prediabetes. However, its use for prediabetes may be considered off-label by healthcare providers in certain cases, especially for individuals at high risk of progressing to type 2 diabetes.

  • FDA Approval: Mounjaro is currently approved for managing blood sugar in adults with type 2 diabetes.
  • Off-Label Use: Some doctors may prescribe it for prediabetes if they believe it could help prevent the progression to diabetes.
  • Consult Your Doctor: Always consult with your healthcare provider to determine if Mounjaro is appropriate for your specific condition.

For prediabetes, lifestyle changes such as diet, exercise, and weight management are typically the first-line recommendations.

Last updated: 1/15/2025

Related Topics